Login to Your Account



Other News To Note


Tuesday, October 1, 2013
Cardiome Pharma Corp., of Vancouver, British Columbia, said that the Medicines Control Council of South Africa approved Brinavess (vernakalant intravenous) for atrial fibrillation.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription